Skip to main content

Tons of Turkey Bacon Products Recalled Due to Possible Listeria Contamination

By Denise Mann HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on July 3, 2025.

via HealthDay

THURSDAY, July 3, 2025 — Kraft Heinz Foods is recalling some 370,000 pounds of fully cooked turkey bacon products that may be contaminated with listeria, the U.S. Department of Agriculture's (USDA) Food Safety and Inspection Service said.

Listeria is a type of bacteria that can contaminate food and cause listeriosis, a serious infection that primarily strikes older adults, people with weakened immune systems, and pregnant women and their newborns.

Symptoms of listeriosis can include fever, muscle aches, headache, stiff neck, confusion, loss of balance and convulsions, sometimes preceded by diarrhea or other gastrointestinal symptoms, according to the USDA.

The contamination was discovered via laboratory testing. There have been no confirmed reports of illness due to consumption of the recalled turkey bacon products.

The recalled products were produced from April 24, 2025, through June 11, 2025.

Items include:

These products have the USDA mark of inspection on the front of the label. They were shipped to retail locations nationwide. Some were exported to the British Virgin Islands and Hong Kong.

Consumers who have purchased these products are urged not to consume them. These products should be thrown away or returned to the place of purchase. Individuals who are concerned about potential illness should consult their healthcare provider.

Consumers with food safety questions can call the toll-free USDA Meat and Poultry Hotline at 888-674-6854.

Sources

  • U.S. Department of Agriculture, news release, July 2, 2025

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Read this next

Study Compares Benefits, Harms of Treatments for Chronic Hives

WEDNESDAY, July 23, 2025 -- Omalizumab and remibrutinib may be the most effective treatments for reducing hives, itch, and swelling with chronic urticaria, according to a study...

USPSTF Guidelines of Little Value for Estimating Preeclampsia Risk in Those at Moderate Risk

WEDNESDAY, July 23, 2025 -- Moderate U.S. Preventive Services Task Force (USPSTF) preeclampsia risk factors have little value for estimating the risk for preeclampsia, according...

Endocrine Society, July 12-15

The annual meeting of the Endocrine Society (ENDO 2025) was held from July 12 to 15 in San Francisco, attracting more than 7,000 participants, including clinicians, academicians...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.